Business Information
The group's principal activities are to develop, manufacture and market immunoassay and bioluminescence-based test kits for detection of a wide variety of substances in the food safety and water quality markets and also provides antibody and immunoreagent research, development andproduction services to medical diagnostic and pharmaceutical companies, as well as research institutions. The group's test kits include chemicals used to treat drinking water, proprietary chemicals used in industries, environmental contaminants, pesticides, genetically engineered traits and diseases in crops. The group provides developing and marketing test kits and strip tests, fully integrated monoclonal antibody development and manufacturing services to pharmaceutical and medical diagnostic companies through its subsidiary. The group markets its products through a network of over 50 distributors in Canada, Mexico, Latin America, Europe and Asia.
|
|
Name |
Title
|
Email
|
| Grover Wrenn | Chmn. | N/A | | Stanley Fronczkowski | CFO, VP - Finance, Corp. Sec. | N/A | | James Stave | VP - Research, Development | N/A | | Clifford Spiro | Dir. | N/A | | Herbert Lotman | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 25,522 | 684 | | 2005 | 24,845 | 584 | | 2004 | 23,705 | 1,379
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
